参考文献:[1] Cancer statistics in China, 2015. CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32.[2] Chollet-Hinton L, Olshan AF, Nichols HB, et al. Biology and etiology of young-onset breast cancers among premenopausal african american women: results from the amber consortium[J]. Cancer Epidemiol Biomarkers Prev, 2017, 26(12): 1722-1729.[3] Pusztai L, Foldi J, Dhawan A, et al. Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early stage breast cancers[J]. Lancet Oncol, 2019, 20(7): e390-e396.[4] Chollet-Hinton L, Olshan AF, Nichols HB, et al. Biology and etiology of young-onset breast cancers among premenopausal african american women: results from the amber consortium[J]. Cancer Epidemiol Biomarkers Prev, 2017, 26(12): 1722-1729.[5]王彬,李燕姿.年轻乳腺癌患者生育力保存的治疗与伦理思考[J].中国医学伦理学.2021(1).88~92.doi:10.12026/j.issn.1001-8565.2021.01.17.[6]黄少浩,罗均胜,招雄民,等.乳腔镜下、常规腋窝淋巴结清扫术治疗乳腺癌的临床效果分析[J].中国医学创新.2020,(8).27~31.